Evidence map›Paper›PMID 40547457›Full record

ArticleFrontiers in public health2025

An unsupervised cluster analysis of multimorbidity patterns in older adults in Shenzhen, China.

Xiaolong Guo, Peiyi Liu, Jing Guo, Naiwen Zhang, Haiyan Huang, Jianjun Liu, Zhen Tan, Guo Dan

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaolong Guo *School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
Peiyi Liu *Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Jing Guo *Endocrinology and Metabolism, Shenzhen University General Hospital, Shenzhen, China.
Naiwen ZhangSchool of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
Haiyan HuangShenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Jianjun LiuShenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Zhen TanHealth Management Center, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.
Guo DanSchool of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Population aging challenges health care systems due to the high prevalence and impact of multimorbidity in older adults. Studies on multimorbidity in Shenzhen have primarily focused on the quantity of multimorbidity, lacking in-depth exploration of multimorbidity patterns. Methods: Based on baseline data from the Shenzhen aging-related disease cohort, this study analyzed information from 8,911 people aged 60 and above after excluding missing and abnormal values from interview results. Using self-organizing map combined with weighted k-means, the distribution of diseases in the population was visualized, dividing the overall population into four clusters. The study also analyzed comorbidity and association rules for each cluster. Result: This study found a high prevalence of cardiometabolic comorbidities among the older adult in Shenzhen, reaching 15.83%, and detailed the distribution of specific comorbidity combinations. Hypertension had a high prevalence and was the most common factor in comorbidities among Shenzhen's older adult. Additionally, hyperuricemia was included as a disease to explore its multimorbidity patterns with other chronic conditions. Conclusion: The study found that multimorbidity is prevalent among the older adult in Shenzhen and explored their patterns, suggesting that Shenzhen should enhance screening and integrated management of high-risk groups and implement public health interventions to alleviate the multimorbidity burden.

Indexed as

MultimorbidityAgedAged, 80 and overChinaChronic DiseaseCluster AnalysisCohort StudiesComorbidityFemaleHumansHypertensionMaleMiddle AgedPrevalencemultimorbiditymultimorbidity patternolder adultsShenzhen cityunsupervised learning

Identifiers

PMID40547457
PMCPMC12180302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.